Contribution By Saipriya Iyer
The injection works by mimicking the GLP-1 hormone that is usually produced in the gut and reduces blood glucose levels experienced post meal.
The EU licensing of the drug is based upon the results of the SUSTAIN clinical trial program.
The facility’s first phase consists of the liquid antioxidants, power blending and formgiving units, which are now operational.
Reports confirm that German chemicals giant BASF has opened the first phase of its new, world-class antioxidants manu
The facility will create around 400 jobs in the region with plans to begin operation by the end of 2021.
Alphabet Inc. owned self-driving car company, Waymo LLC has recently received approval to set up a manufacturing facility in Michigan for buil
The acquisition is expected to help Lactalis lower its dependency on domestic markets in Europe.
Prabhat Dairy, a milk-processing company based in India, has recently announced that it will be selling its Maharashtra-based business to the French m